AptarGroup, Inc. with ticker code (ATR) now have 4 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between 152 and 125 with the average target price sitting at $138.50. Given that the stocks previous close was at $122.93 this now indicates there is a potential upside of 12.7%. The 50 day MA is $125.55 and the 200 moving average now moves to $118.67. The total market capitalization for the company now stands at 8.03B. The stock price for the company is currently 122.37 USD
The potential market cap would be $9,049,326,461 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 32.37, revenue per share of 52.61 and a 6.29% return on assets.
AptarGroup, Inc. is a designer and manufacturer of a range of drug delivery and consumer product dispensing, sealing and active packaging solutions and services. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma includes operations that sells dispensing systems and sealing solutions and also manufactures and sells elastomeric primary packaging components. The Company’s products include stoppers for infusion, antibiotic, lyophilization and diagnostic vials. The Aptar Beauty segment includes operations that sell dispensing systems, drug delivery systems, sealing solutions and services to the prescription drug, consumer health care, injectables, and active material science solutions markets. The Aptar Closures business serves multiple markets, including food, beverage, personal care, home care, beauty and healthcare. This segment offers food protection business and elastomeric flow-control technology business.
